News on in vitro diagnostics for musculoskeletal disorders.
Bionano Genomics Launches CLIA-Certified Laboratory, First OGM-Based Test
Bionano Laboratories will offer services to clinical customers seeking to implement OGM for routine diagnostic use.
PerkinElmer is providing its recently FDA-approved test for the program, which has identified one baby, so far, as positive for DMD.
PerkinElmer's Muscular Dystrophy Screening Kit Receives FDA Marketing Authorization
The company's GSP Neonatal Creatine Kinase-MM kit measures the CK-MM protein and is the first test to help in newborn screening for Duchenne Muscular Dystrophy.
Invitae, BioMarin Partner on Access to Genetic Testing for Skeletal Dysplasias
Invitae will provide genetic testing for 109 genes associated with the conditions, while BioMarin will provide financial support for the program.
Sanofi Genzyme, PerkinElmer Launch Free Dx Program for Patients With Lysosomal Storage Disorders
The Lantern Project will screen for patients who may be suffering from Gaucher disease, Fabry disease, Pompe disease, MPS I, or ASMD, and offer confirmatory DNA testing.